Baillie Gifford & Co’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.59M | Sell |
|
|||||
|
2024
Q2 | $12.4M | Sell |
|
|||||
|
2024
Q1 | $12.8M | Sell |
|
|||||
|
2023
Q4 | $15.1M | Sell |
|
|||||
|
2023
Q3 | $14.4M | Sell |
|
|||||
|
2023
Q2 | $13.6M | Sell |
|
|||||
|
2023
Q1 | $11.9M | Sell |
|
|||||
|
2022
Q4 | $12.6M | Buy |
|
|||||
|
2022
Q3 | $14.4M | Buy |
|
|||||
|
2022
Q2 | $11.5M | Sell |
|
|||||
|
2022
Q1 | $12.9M | Buy |
|
|||||
|
2021
Q4 | $9.61M | Buy |
|
|||||
|
2021
Q3 | $10.1M | Buy |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $10.7M | Buy |
|
|||||
|
2020
Q4 | $7.14M | Sell |
|
|||||
|
2020
Q3 | $233M | Sell |
|
|||||
|
2020
Q2 | $485M | Sell |
|
|||||
|
2020
Q1 | $413M | Sell |
|
|||||
|
2019
Q4 | $531M | Buy |
|
|||||
|
2019
Q3 | $504M | Sell |
|
|||||
|
2019
Q2 | $543M | Sell |
|
|||||
|
2019
Q1 | $702M | Sell |
|
|||||
|
2018
Q4 | $473M | Sell |
|
|||||
|
2018
Q3 | $462M | Sell |
|
|||||
|
2018
Q2 | $387M | Buy |
|
|||||
|
2018
Q1 | $276M | Sell |
|
|||||
|
2017
Q4 | $333M | Sell |
|
|||||
|
2017
Q3 | $353M | Sell |
|
|||||
|
2017
Q2 | $379M | Sell |
|
|||||
|
2017
Q1 | $314M | Sell |
|
|||||
|
2016
Q4 | $402M | Sell |
|
|||||
|
2016
Q3 | $311M | Sell |
|
|||||
|
2016
Q2 | $202M | Buy |
|
|||||
|
2016
Q1 | $335M | Buy |
|
|||||
|
2015
Q4 | $500M | Buy |
|
|||||
|
2015
Q3 | $319M | Buy |
|